Hong Kong AI Drug Startup Soars 185% on $270M Debut
While Silicon Valley argues about AI valuations in the abstract, Hong Kong just watched investors put $270 million into drug delivery algorithms and get a 185% first-day return. Metis TechBio raised HK$2.1 billion ($270 million) in its Hong Kong IPO, using AI for drug delivery and formulation
Continue reading ›